Forschung, Karl Landsteiner Privatuniversität, Uniklinikum

Research projects

Forschung, Karl Landsteiner Privatuniversität, KRIS

Research portal KRIS

KL Research Information System

The research portal KRIS (Karl Landsteiner information system) presents the entire research output of researchers at Karl Landsteiner University of Health Sciences. The portal facilitates searches for research outputs, people and organisational units. Publications, research projects, awards and memberships are all presented in a clear and consistent way on KRIS. KRIS enables experts to network and ensures the visibility of public research activities.
The following overview provides a brief outline of the latest projects. For more information, click on the link for KRIS.

Overview of KL research projects

Ein 3D Model des Immun-Knochenmilieus zur Metastasenforschung

Role of MIC-A and MIC-B on tumor cells

Investigating the role of MIC-A and MIC-B on tumor cells

PROTACs

Targeting Transcription factors for cancer therapy utilizing PROteolysis-TArgeting Chimera (PROTACs)

Palliative Care bei PatientInnen mit fortgeschrittenem Bronchialkarzinom

Evaluierung des Gesamtüberlebens sowie der Einbindung von Palliativ Care bei PatientInnen mit fortgeschrittenem nicht kleinzelligem Bronchialkarzinom im Stadium IV seit 2008 am Universitätsklinikum Krems

ICI and Bone Turnover

Untersuchung der Effekte von Immun-Checkpoint Inhibitoren auf den Knochenumbau.

Vertragsprüfung der klinischen Studie: Single Arm Phase II-Study in Patients with extensive stage small-cell lung cancer (ES-SCLC) with poor performance Staus receiving Atezolizumab-Carboplatin-Etoposide

Biomarker- based therapeutic prevention

Biomarker- based therapeutic prevention of bone metastases in breast cancer. Defining the pathophysiologic impact of the endosteal niche

Tumor Cachexia

JAK2 inhibitors

JAK2 inhibitors and the innate immune response in mutant CALR-driven MPNs

APOG NÖ

ACCESS POINT Oncology

ATEOL-LA

Prevalence, costs, and impact of anticancer treatment and Palliative Care Services at the end of life of patients with advanced lung cancer in Lower Austria

Fight Cancer

Unraveling the pathogenesis to improve treatment of cancer metastasis

BONE

Biomarker- based therapeutic prevention of bone metastases in breast cancer: Defining the pathophysiologic impact of the endosteal niche

Systemische Antitumortherapie am Lebensende

Retrospektive Analyse der Inzidenz und der Kosten medikamentöser Antitumortherapie (Chemotherapie, „Small Molecules“, zielgerichtete Antikörpertherapie, Immuncheckpoint-Inhibitoren) in der letzten Lebensphase bei PatientInnen mit soliden Tumoren in Krems